Cargando…

Prenatal Selective Serotonin Reuptake Inhibitor Exposure, Depression, and Brain Morphology in Middle Childhood: Results From the ABCD Study

BACKGROUND: Prenatal selective serotonin reuptake inhibitor (SSRI) exposure has been inconsistently linked to depression, and little is known about neural correlates. We examined whether prenatal SSRI exposure is associated with depressive symptoms and brain structure during middle childhood. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moreau, Allison L., Voss, Michaela, Hansen, Isabella, Paul, Sarah E., Barch, Deanna M., Rogers, Cynthia E., Bogdan, Ryan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Archival Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140451/ https://www.ncbi.nlm.nih.gov/pubmed/37124359 http://dx.doi.org/10.1016/j.bpsgos.2022.02.005

Ejemplares similares

Diminished Neural Processing of Aversive and Rewarding Stimuli During Selective Serotonin Reuptake Inhibitor Treatment
por: McCabe, Ciara, et al.
Publicado: (2010)

Prenatal exposure to serotonin reuptake inhibitors: a case report
por: Marsella, Maria, et al.
Publicado: (2010)

Replication of Associations With Psychotic-Like Experiences in Middle Childhood From the Adolescent Brain Cognitive Development (ABCD) Study
por: Karcher, Nicole R, et al.
Publicado: (2020)

Longitudinal Impact of Childhood Adversity on Early Adolescent Mental Health During the COVID-19 Pandemic in the ABCD Study Cohort: Does Race or Ethnicity Moderate Findings?
por: Stinson, Elizabeth A., et al.
Publicado: (2021)

The ABCD study: understanding the development of risk for mental and physical health outcomes
por: Karcher, Nicole R., et al.
Publicado: (2020)

S28. ADVERSE CHILDHOOD EXPERIENCES AND PSYCHOTIC-LIKE EXPERIENCES ARE ASSOCIATED ABOVE AND BEYOND SHARED CORRELATES: FINDINGS FROM THE ADOLESCENT AND BRAIN COGNITIVE DEVELOPMENT (ABCD) STUDY
por: Karcher, Nicole, et al.
Publicado: (2020)

Estimating the Association Between Exposome and Psychosis as Well as General Psychopathology: Results From the ABCD Study
por: Pries, Lotta-Katrin, et al.
Publicado: (2022)

The Risk of Congenital Heart Anomalies Following Prenatal Exposure to Serotonin Reuptake Inhibitors—Is Pharmacogenetics the Key?
por: Daud, Aizati N. A., et al.
Publicado: (2016)

Sentiment Analysis of Online Reviews for Selective Serotonin Reuptake Inhibitors and Serotonin–Norepinephrine Reuptake Inhibitors
por: Compagner, Chad, et al.
Publicado: (2021)

Acculturative Orientations Among Hispanic/Latinx Caregivers in the ABCD Study: Associations With Caregiver and Youth Mental Health and Youth Brain Function
por: Meca, Alan, et al.
Publicado: (2023)

Identifying reproducible individual differences in childhood functional brain networks: An ABCD study
por: Marek, Scott, et al.
Publicado: (2019)

The Association Between Maternal Cortisol and Infant Amygdala Volume Is Moderated by Socioeconomic Status
por: Herzberg, Max P., et al.
Publicado: (2023)

Clinical pharmacology of serotonin selective reuptake inhibitors /
por: Preskorn, Sheldon
Publicado: (1996)

Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia
por: Welsch, Patrick, et al.
Publicado: (2018)

Selective serotonin reuptake inhibitors and Alzheimer’s disease
por: Mdawar, Bernadette, et al.
Publicado: (2019)

Candidate genes for antidepressant response to selective serotonin reuptake inhibitors
por: Lotrich, Francis E, et al.
Publicado: (2005)

Serotonin syndrome triggered by postoperative administration of serotonin noradrenaline reuptake inhibitor (SNRI)
por: Takata, Junko, et al.
Publicado: (2019)

Infant and childhood neurodevelopmental outcomes following prenatal exposure to selective serotonin reuptake inhibitors: overview and design of a Finnish Register-Based Study (FinESSI)
por: Malm, Heli, et al.
Publicado: (2012)

Clinical Utility of Semistructured Interview and Scales to Assess Withdrawal Syndromes With Dose Reduction or Discontinuation of Selective Serotonin Reuptake Inhibitors or Serotonin Norepinephrine Reuptake Inhibitors
por: Cosci, Fiammetta, et al.
Publicado: (2022)

Delineating and validating higher-order dimensions of psychopathology in the Adolescent Brain Cognitive Development (ABCD) study
por: Michelini, Giorgia, et al.
Publicado: (2019)

ROS-Scavenging Selenofluoxetine Derivatives Inhibit In Vivo Serotonin Reuptake
por: Ribaudo, Giovanni, et al.
Publicado: (2022)

Prenatal serotonin reuptake inhibitor (SRI) antidepressant exposure and serotonin transporter promoter genotype (SLC6A4) influence executive functions at 6 years of age
por: Weikum, Whitney M., et al.
Publicado: (2013)

Effect of Serotonin Reuptake Inhibitors on Pulmonary Hemodynamics in Humans
por: Pleym, Hilde, et al.
Publicado: (2011)

Serotonin reuptake inhibitor antidepressants (SSRIs) against atherosclerosis
por: Wozniak, Greta, et al.
Publicado: (2011)

Heart Rate Recovery and Selective Serotonin Reuptake Inhibitors
por: Cerit, Levent
Publicado: (2016)

Selective serotonin reuptake inhibitor-induced galactorrhea with hyperprolactinemia
por: Bhattacharjee, Subir, et al.
Publicado: (2021)

Confounding by Indication in Studies of Selective Serotonin Reuptake Inhibitors
por: Lee, Jimin, et al.
Publicado: (2022)

Comparison of the Antidepressant-Like Effects of Estradiol and That of Selective Serotonin Reuptake Inhibitors in Middle-Aged Ovariectomized Rats
por: Benmansour, Saloua, et al.
Publicado: (2016)

Kidney function and prescribed dose in middle‐aged and older patients starting selective serotonin reuptake inhibitors
por: Zhu, Nanbo, et al.
Publicado: (2022)

Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants, Prolactin and Breast Cancer
por: Ashbury, Janet E., et al.
Publicado: (2012)

High-Dose Testosterone Treatment Increases Serotonin Transporter Binding in Transgender People
por: Kranz, Georg S., et al.
Publicado: (2015)

Transient Serotonin Syndrome Caused by Concurrent Use of Tramadol and Selective Serotonin Reuptake Inhibitor
por: Shakoor, Muhammad Tariq, et al.
Publicado: (2014)

Selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors for anxiety, obsessive-compulsive, and stress disorders: A 3-level network meta-analysis
por: Gosmann, Natan Pereira, et al.
Publicado: (2021)

The Efficacy and Safety of Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors in the Treatment of Menopausal Hot Flashes: A Systematic Review of Clinical Trials
por: Azizi, Marzieh, et al.
Publicado: (2022)

Overcoming Resistance to Selective Serotonin Reuptake Inhibitors: Targeting Serotonin, Serotonin-1A Receptors and Adult Neuroplasticity
por: Vahid-Ansari, Faranak, et al.
Publicado: (2019)

The Serotonin Transporter Gene Alters Sensitivity to Attention Bias Modification: Evidence for a Plasticity Gene
por: Fox, Elaine, et al.
Publicado: (2011)

Whole-Brain Resting-State Functional Connectivity Patterns Associated With Pediatric Anxiety and Involuntary Attention Capture
por: Perino, Michael T., et al.
Publicado: (2021)

Improvement of social adaptation in depression with serotonin and norepinephrine reuptake inhibitors
por: Briley, Mike, et al.
Publicado: (2010)

Serotonin-Norepinephrine Reuptake Inhibitors for Pain Control: Premise and Promise
por: Marks, David M, et al.
Publicado: (2009)

Bioimpedance in monitoring of effects of selective serotonin reuptake inhibitor treatment
por: Alexeev, Vasiliy Grigorievich, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_qpfqf6hardf2fov7k5etpsmaaf